Vitamin A was used to treat night blindness by Egyptian physicians as
early as 1500 BC. All compounds that exhibit pharmacological and physi
ological properties of the basic vitamin A alcohol moiety are nowadays
referred to as retinoids. Retinoids have been investigated fbr use in
the treatment of various ocular diseases such as xerophthalmia, corne
al wounds, dry-eye disorders and even proliferative vitreoretinopathy.
In the beginning, retinoids were administered topically by mixing the
m with oils or through ointments. However, more recently, the emphasis
has been on developing systems for controlled release of retinoids, m
ainly by using biopolymers. Topical application has a great advantage
in that it will overcome some of the serious side effects of systemica
lly or orally administered retinoids. Along with the development of co
ntrolled release systems, new derivatives of currently available retin
oids have been developed in order to achieve a better drug. This revie
w summarizes various publications dealing with the local administratio
n of retinoids either by topical route or by intravitreous route in an
imals and humans to treat various ocular diseases. (C) 1997 Elsevier S
cience B.V.